Page 30 - Journal of Structural Heart Disease Volume 1, Issue 3

Original Scientific Article
136
MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the Eu- ropean Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42:S1-44. DOI: 10.1093/ejcts/ezs455
8. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D, et al. Acute outcomes of MitraClip therapy for mitral regurgi- tation in high-surgical-risk patients: Em- phasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J. 2010;31:1373-1381. DOI: 10.1093/ eurheartj/ehq050
9. Tamburino C, Ussia GP, Maisano F, Capodan- no D, La Canna G, Scandura S, et al. Percuta- neous mitral valve repair with the MitraClip system: Acute results from a real world set- ting. Eur Heart J. 2010;31:1382-1389. DOI: 10.1093/eurheartj/ehq051
10. Auricchio A, Schillinger W, Meyer S, Maisa- no F, Hoffmann R, Ussia GP, et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and pro- motes reverse remodeling. J Am Coll Car- diol. 2011;58:2183-2189. DOI: 10.1016/j. jacc.2011.06.061
11. Rudolph V, Lubos E, Schluter M, Lubs D, Goldmann B, Knap M, et al. Aetiology of mitral regurgitation differentially affects 2-year adverse outcomes after MitraClip
therapy in high-risk patients. Eur J Heart Failure. 2013;15:796-807. DOI: 10.1093/ eurjhf/hft021
12. Wiebe J, Franke J, Lubos E, Boekstegers P, Schillinger W, Ouarrak T, et al. Percutane- ous mitral valve repair with the MitraClip system according to the predicted risk by the logistic EuroSCORE: Preliminary re- sults from the German Transcatheter Mi- tral Valve Interventions (TRAMI) Registry. Catheter Cardiovasc Interv. 2014;84:591- 598. DOI: 10.1002/ccd.25493
13. Feldman T, Kar S, Rinaldi M, Fail P, Her- miller J, Smalling R, et al. Percutaneous mitral repair with the MitraClip system: Safety and midterm durability in the ini- tial EVEREST (Endovascular Valve Edge- to-Edge REpair Study) cohort. J Am Coll Cardiol. 2009;54:686-694. DOI: 10.1016/j. jacc.2009.03.077
14. Maisano F, Franzen O, Baldus S, Schafer U, Hausleiter J, Butter C, et al. Percutane- ous mitral valve interventions in the real world: Early and 1-year results from the AC- CESS-EU, a prospective, multicenter, non- randomized post-approval study of the MitraClip therapy in Europe. J Am Coll Car- diol. 2013;62:1052-1061. DOI: 10.1016/j. jacc.2013.02.094
15. Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol. 2014;64:172-181. DOI: 10.1016/j.jacc.2013.12.062
16. Whitlow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R, et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Car- diol. 2012;59:130-139. DOI: 10.1016/j. jacc.2011.08.067
17. Mauri L, Foster E, Glower DD, Apruzzese P, Massaro JM, Herrmann HC, et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Car- diol. 2013;62:317-328. DOI: 10.1016/j. jacc.2013.04.030
Journal of Structural Heart Disease, August 2015
Volume 1, Issue 3: 127-136
Cite this article as: Sharma R, Makar M, Kar S. An Overview of the Mitraclip Procedure. Structural Heart Disease 2015;1(3):127-136. DOI: http://dx.doi. org/10.12945/j.jshd.2015.018-14